Tilray: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value
Free cash flow over the last three years averaged below zero, so a cash-flow value cannot be worked out.
Your own DCF model
A full discounted-cash-flow model of Tilray, started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelAgainst the industry Pharmaceutical
Multiples of its companies with a market value at most 60 days old, times Tilray's own figures of FY2025.
| Multiple | Peers (25th / median / 75th) | Tilray | Applied to | Value (25th to 75th) | Companies |
|---|---|---|---|---|---|
| Price to sales | 1.6× / 3.5× / 6.7× | 0.3× | revenue $915 M | $1.4 B to $6.1 B | 68 |
| Price to book | 2.1× / 4.1× / 8.3× | 0.1× | book equity $1.6 B | $3.4 B to $13.4 B | 62 |
Peers' multiples from the distributions by industry; the company's figures from its statements below. A multiple says what similar companies cost, not what this one is worth.
The statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2025to May 31, 2026 | $915 M | $-121 M | $-69 M | — | — | $-106 M | SEC annual report (10-K, 20-F) |
| FY2024to May 31, 2025 | $821 M | $-2.2 B | $-95 M | $33 M | $-128 M | — | SEC annual report (10-K, 20-F) |
| FY2023to May 31, 2024 | $789 M | $-245 M | $-31 M | $29 M | $-60 M | — | SEC annual report (10-K, 20-F) |
| FY2022to May 31, 2023 | $627 M | $-1.5 B | $8 M | $21 M | $-13 M | — | SEC annual report (10-K, 20-F) |
| FY2021to May 31, 2022 | $628 M | $-477 M | $-177 M | $34 M | $-211 M | $-230 M | SEC annual report (10-K, 20-F) |
| FY2020to May 31, 2021 | $513 M | $-271 M | $-129 M | $45 M | $-174 M | $-284 M | SEC annual report (10-K, 20-F) |
Each figure as filed; the full statements with every line and its filing are on the company page. Market value $241 M on Oct 31, 2026.
How it is worked out: the cash-flow value is free cash flow grown at the first-stage rate for the years chosen, then at the long-run rate for ever, each year discounted at the risk-free rate plus the equity risk premium, less net debt. What the price assumes is the first-stage growth that makes that value equal today's market value. The starting cash flow, growth and net debt come from the statements; the risk-free rate from the US Treasury; the premium and the long-run growth are assumptions and are labelled so. This is arithmetic on reported figures, not advice.